Target Group's Cash Drops to $5,914 as Losses Double and Debt Defaults
CBDY sits 71% above its 52-week low of $0.001 on elevated volume (2.7× avg).
Summary
Target Group's Q2 2026 filing reveals cash of just $5,914, a net loss that doubled to $790,168, and a $7.3 million related-party loan in default — a sharp deterioration from the prior quarter.
Key Events · Earnings and Guidance · CBDY
-
Cash Nearly Exhausted
Cash fell to $5,914 as of June 30, 2026, from $100,410 at December 31, 2025. Total cash and restricted cash is only $14,006.
-
Net Loss More Than Doubles
Six-month net loss was $790,168, up from $327,983 in the prior-year period, driven by higher interest expense and lower gross profit.
-
Related-Party Loan in Default
The $7,334,333 CLI loan is in default and classified as a current liability. No payments were made during the period, and terms are under renegotiation.
-
Working Capital Deficit Widens
Working capital deficit increased to $11,232,219 from $11,052,097 at year-end, reflecting growing current liabilities.
Analysis · CBDY · Life Sciences
Target Group's second-quarter report shows a rapidly deteriorating financial position. Cash has fallen to just $5,914, down from $100,410 at year-end, while the six-month net loss more than doubled to $790,168. The company's working capital deficit widened to $11.2 million, and its related-party CLI loan of $7.3 million is now in default and due on demand. With only $14,006 in total cash and restricted cash, the company's ability to continue operations without immediate financing is severely constrained. The going-concern warning from the prior quarter is now backed by concrete numbers showing the runway is nearly exhausted.
At the time of this filing, CBDY was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $740.4K. The 52-week trading range was $0.00 to $0.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.